Search results
You searched for:
Found 2,029 results
Sorting options:
Date: 01/01/2026 Location: Other
Early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. This course will show GPs how to identify cirrhosis, how to prevent and manage the complications of cirrhosis, and the important role they play in the integrated care of the patient with cirrhosis.
1.5 Educational activity hours
0.5 Performance review hour
Date: 01/01/2026 Location: Other
This on-demand activity will provide GPs with vital information to enhance their confidence and knowledge around the role of nutrition and lifestyle in preventing and managing cardiovascular disease (CVD). By participating, GPs will be better equipped to discuss and offer practical dietary and lifestyle advice to patients, supporting improved heart health outcomes in everyday practice. andlt;grammarly-desktop-integration data-grammarly-shadow-root="true"andgt;andlt;/grammarly-desktop-integrationandgt;
2.5 Educational activity hours
Date: 01/01/2026 Location: Other
GPs play an important role in the early identification, evaluation and monitoring of patients with rarer liver diseases. This module will provide an overview of the rarer liver disease and highlight the red flags that indicate urgent specialist review or hospitalisation.
1 Educational activity hour
Date: 01/01/2026 Location: Other
The aim of this clinical audit is for GPs to conduct an assessment of patients who are at risk of metabolic associated fatty liver disease (MAFLD) to assess their risk of liver fibrosis and guide their future management.
1 Educational activity hour
1 Performance review hour
4 Outcome measurement hours
Date: 01/01/2026 Location: Other
This clinical audit activity presents latest evidence-based recommendations and PBS pathways for reducing cardiorenal risk in people with type 2 diabetes and comorbid cardiovascular disease, multiple cardiovascular risk factors and/or kidney disease. It also provides a practical framework for optimising the care of patients with T2D who are facing enhanced cardiorenal risk, using lifestyle and guideline-directed medical therapies.
1.5 Educational activity hours
1 Performance review hour
4 Outcome measurement hours
Date: 01/01/2026 Location: Other
Five years on from the start of COVID-19, the acute phase of the pandemic has passed but variants continue to circulate with periodic increases in transmission. For GPs and their patients, staying informed and proactive is crucial, especially for vulnerable people who continue to be at risk of harm. In this on-demand webinar, you willgain the latest updates in epidemiology, evidence and best practice in primary care, as we begin to evolve towards a longer-term approach to COVID-19 in our communities. Presented by infectious disease physician Assoc. Prof Paul Griffin and GP Dr Anita Munoz, join us for this very important COVID 2025 update.
1.5 Educational activity hours
Date: 01/01/2026 Location: Other
Following an on-demand webinar GPs are invited to complete a clinical audit in which they identify patients with COPD who have a history of moderate to severe exacerbations in the past 12 months and an increased risk of cardiovascular events. The audit will encourage GPs to consider how the patient’s self-management behaviours, inhaled COPD medications and prescribed non-pharmacological treatments could be further optimised, in line with evidence-based guidelines, to improve symptom control and reduce the risk of further exacerbations.
1 Performance review hour
4 Outcome measurement hours
1.5 Educational activity hours
Date: 01/01/2026 Location: Other
This course introduces and defines the features and pathogenisis of metabolic syndrome and insulin resistance. General practitioners are uniquely placed to diagnose and manage this condition. Screening tools, medical complications and risk factors are explained together with the complexities, incidence and prevalence of metabolic syndrome and insulin resistance. Common features of this condition are described including abdominal (visceral) obesity, insulin resistance, dyslipidaemia and microalbuminuria. Risk factors affecting the endocrine, cardiovascular and gastrointestinal systems are outlined as well as the relationship with coronary heart disease and non-alcoholic fatty liver disease. The role of the gut microbiome in patients with metabolic syndrome is mentioned. A case study reinforces learning. The second section focusses on environmental determinants including lifestyle choices, nutrition, physical activity and medications. Low energy and ketogenic states are detailed in addition to a change in overall dietary patterns. Referral options to dieticians and surgery are mentioned. A case study concludes this course. andlt;grammarly-desktop-integration data-grammarly-shadow-root="true"andgt;andlt;/grammarly-desktop-integrationandgt;
6 Performance review hours
4 Educational activity hours
Date: 01/01/2026 Location: Other
This module gives an in-depth look at severe asthma in the Australian landscape, and the impact that it has on patients. The module explores the role of the wider medical team, including specialists, and guides participants through the SIMPLES approach to optimising management for patients with difficult-to-treat asthma. The module also gives an overview on utilising spirometry in a primary care setting, and provides practical treatment tips for rural and remote patients.
1 Educational activity hour
Date: 01/01/2026 Location: Other
The course focuses on the changing nutritional requirements for patients diagnosed with cancer across treatment, during survivorship and end-stage care. As some cancer treatments can affect appetite, patients may be at nutritional risk – the ESPEN guide outlines the three categories for patients at risk: precachexia, cachexia and refractory cachexia. Multi-modal treatments are discussed including dietary counselling and sample meal plans. Nutritional recommendations for minimizing recurrence risk are listed. The GP and dietitian’s roles are outlined for managing these patients. The second section suggests recommended evidence-based nutrition management to improve the nutritional status and quality of life for patients with cancer. Omega-3 fatty acids and other ‘hot topics’ including ginger and adjuvant therapies are mentioned. The impact of chemotherapy on nutrition and gastronomy is explained. In end stage care, nutritional focus is for symptom management and quality of life. Evidence-based guidelines and research support the course content. andlt;grammarly-desktop-integration data-grammarly-shadow-root="true"andgt;andlt;/grammarly-desktop-integrationandgt;
4.5 Educational activity hours
6 Performance review hours